Lung Cancer Trial, Recruiting NCT03786003 Sponsor: Fudan University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT03786003
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose cancer is at an early stage (T1N0M0), meaning it has not spread to nearby lymph nodes or other parts of the body, and can be removed with surgery.
  • People whose lung tumour appears solid (not part solid or hollow) on a CT scan.
  • People aged between 18 and 75 years old.
  • People who have signed a consent form agreeing to take part in the trial.

Who may not be able to join:

  • People whose tissue sample analysis shows the cancer is not non-small cell lung cancer (NSCLC).
  • People who did not have a lobectomy (removal of a section of the lung) or a sublobar resection (removal of a smaller portion of the lung) as their surgery.
  • People who have had another type of cancer in the past 5 years.
  • People who have previously had chest surgery, or for whom keyhole-style chest surgery (known as VATS) is not suitable.
  • People who have previously had radiation therapy or chemotherapy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 February 2022
Est. completion
9 February 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov